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Hepatocytes provide most liver functions, but they
can also proliferate and regenerate the liver after
injury. However, under some liver injury conditions,
particularly chronic liver injury where hepatocyte
proliferation is impaired, liver stem cells (LSCs) are
thought to replenish lost hepatocytes. Conflicting
results have been reported about the identity of
LSCs and their contribution to liver regeneration.
To address this uncertainty, we followed candidate
LSC populations by genetic fate tracing in adult
mice with chronic liver injury due to a choline-defi-
cient, ethionine-supplemented diet. In contrast to
previous studies, we failed to detect hepatocytes
derived from biliary epithelial cells or mesenchymal
liver cells beyond a negligible frequency. In fact, we
failed to detect hepatocytes that were not derived
from pre-existing hepatocytes. In conclusion, our
findings argue against LSCs, or other nonhepatocyte
cell types, providing a backup system for hepato-
cyte regeneration in this common mouse model of
chronic liver injury.
INTRODUCTION
The adult liver is unique in its ability to efficiently regenerate after
injury. Under most circumstances, liver function is restored
through replacement of damaged hepatocytes by self-duplica-
tion of remaining hepatocytes. However, when hepatocyte pro-
liferation is impaired—as under chronic injury conditions—other
cells may contribute to liver regeneration by giving rise to hepa-
tocytes (Itoh and Miyajima, 2014).
Liver stem cells (LSCs) have long been favored as the
most likely alternative source of hepatocytes in the adult
liver. In the classical view, LSCs are nonhepatocyte precur-
sors of highly proliferative progenitor cells that can differen-
tiate into both hepatocytes and biliary epithelial cells (BECs),thereby providing a backup system for liver regeneration
(Duncan et al., 2009). In support of this view, cells that are
bipotential in vitro can be isolated from the adult mouse liver
(Dorrell et al., 2011; Huch et al., 2013; Shin et al., 2011).
These cells exhibit markers of BECs, which accords with
numerous studies locating LSCs in biliary structures, particu-
larly at the interphase of bile ducts and hepatocyte plates
(Itoh and Miyajima, 2014). However, specific markers of
LSCs have not been identified, and therefore no direct evi-
dence currently exists for a contribution from LSCs to hepato-
cytes in vivo.
In the absence of specific LSC markers, researchers have
resorted to using broader lineage markers to delineate alterna-
tive cell sources of hepatocytes in vivo. Genetic fate-tracing
studies in mice based on SRY (sex determining region Y) box
9 (Sox9), osteopontin (Opn), or hepatocyte nuclear factor 1
beta (Hnf1b) expression support that cells within the BEC
population can differentiate into hepatocytes (Espan˜ol-Sun˜er
et al., 2012; Furuyama et al., 2011; Rodrigo-Torres et al.,
2014). Other studies of fate tracing using a human glial fibril-
lary acidic protein (GFAP) promoter reported that stellate
cells—a mesenchymal liver cell type at the center of liver
fibrosis—can give rise to new hepatocytes (Michelotti et al.,
2013; Swiderska-Syn et al., 2014; Yang et al., 2008). In addi-
tion, hematopoietic cells have been implicated as hepatocyte
precursors, but these findings were later clarified to be due
to cell fusion (Wang et al., 2003). Recent studies not only
have challenged previous reports of stellate cells giving rise
to hepatocytes (Mederacke et al., 2013), but also have raised
doubt about the established concept of a subset of BECs be-
ing—or being able to act as—LSCs by giving rise to hepato-
cytes (Tarlow et al., 2014).
Because of these contradictory findings, the contribution of
LSCs, or any nonhepatocyte cell type, to the formation of new
hepatocytes in the chronically injured liver is uncertain. Here,
we sought to resolve this uncertainty using our previously re-
ported hepatocyte fate-tracing mouse model (Malato et al.,
2011) and mouse models that afford highly specific labeling
and therefore reliable fate tracing of BECs and mesenchymal
liver cells.Cell Reports 8, 933–939, August 21, 2014 ª2014 The Authors 933
Figure 1. Presence of Unlabeled Hepato-
cytes in a Hepatocyte Fate-Tracing Mouse
Model after Chronic Liver Injury
(A) The hepatocyte fate-tracing model was
generated by injecting R26R-EYFP mice with
AAV8-Ttr-Cre. Liver injury was induced by CDE
diet feeding 1 week later. Livers were analyzed
after 3 weeks of CDE diet feeding.
(B) Coimmunostaining for EYFP and Ck19 shows
oval cell expansion characteristic for livers of mice
after CDE diet feeding.
(C) Coimmunostaining for EYFP and Hnf4a shows
EYFP-negative, Hnf4a-positive cells; i.e., non-
fate-traced hepatocytes (arrowheads and inset).
(D) Quantification of non-fate-traced hepatocytes.
Data are shown as mean ± SEM.
Scale bars, 100 mm. Representative images and
results from three mice are shown. See also Fig-
ures S1 and S4B.RESULTS
Hepatocyte Fate Tracing in Choline-Deficient,
Ethionine-Supplemented Diet-Induced Chronic
Liver Injury
To study the contribution of LSCs or other nonhepatocytes
to new hepatocytes, we chose a mouse model of chronic liver
injury caused by a choline-deficient, ethionine-supplemented
(CDE) diet. The CDE diet was originally observed in rats, and
subsequently in mice, to cause emergence of liver progenitor
cells—called oval cells in rodents—from portal tracts, thereby
mimicking ductular reactions observed in chronic liver diseases
in humans (Akhurst et al., 2001; Shinozuka et al., 1978). Although
other chronic liver injury models exist, we focused on CDE diet
feeding because, for mice, it is the only model with which multi-
ple research groups obtained direct evidence for the conversion
of nonhepatocytes into hepatocytes (Espan˜ol-Sun˜er et al., 2012;
Rodrigo-Torres et al., 2014).
To determine the frequency at which new hepatocytes are
formed from nonhepatocytes in CDE-diet-fed mice, we per-
formed hepatocyte fate tracing. For this, we injected Cre recom-
binase reporter (R26R-EYFP)micewith an adenoassociated viral
vector expressing Cre from the transthyretin promoter (AAV8-
Ttr-Cre; Figure 1A). We showed previously that this nonintegrat-
ing vector affords specific and efficient reporter gene activation
in hepatocytes but does not label BECs, stellate cells, macro-
phages, or endothelial cells in livers of R26R-EYFP mice (Malato
et al., 2011). One week after genetically labeling hepatocytes
with AAV8-Ttr-Cre, we started feeding mice the CDE diet. As934 Cell Reports 8, 933–939, August 21, 2014 ª2014 The Authorspreviously reported (Espan˜ol-Sun˜er
et al., 2012; Rodrigo-Torres et al., 2014),
the CDE diet was used for 3 weeks, after
which we confirmed that a characteristic
oval cell response was present—identi-
fied by the expansion of cytokeratin 19
(Ck19)-positive cells or Opn-positive cells
in periportal regions (Figures 1B and
S1A). Next, we analyzed the injured livers
by coimmunostaining for EYFP and thehepatocyte markers hepatocyte nuclear factor 4 alpha (Hnf4a)
and fumarylacetoacetate hydrolase (Fah) for the presence of
EYFP-negative hepatocytes (Figures 1C and S1B). We found
these non-fate-traced hepatocytes at a frequency of 0.76% ±
0.16% (Figure 1D). This result was in accord with results from
previous studies showing that new hepatocytes originate—in
small numbers—from a nonhepatocyte source, presumably
LSCs, in mice with CDE-diet-induced chronic liver injury (Espa-
n˜ol-Sun˜er et al., 2012; Rodrigo-Torres et al., 2014).
Biliary Cell Fate Tracing in CDE-Diet-Induced Chronic
Liver Injury
To determine the source of the observed non-fate-traced hepa-
tocytes, we performed fate tracing of candidate cell populations.
First,we tested thepredominant view that LSCscapable of giving
rise to hepatocytes reside in biliary structures (Espan˜ol-Sun˜er
et al., 2012; Furuyama et al., 2011; Rodrigo-Torres et al., 2014).
Intriguingly, the frequency of non-fate-traced hepatocytes
observed by us was similar to the frequency with which Opn-ex-
pressing cells were previously reported to give rise to hepato-
cytes in the same liver injury model (Espan˜ol-Sun˜er et al.,
2012). However, these results have been called into question
by a recent Sox9-based fate-tracing study in which conversion
of BECs into hepatocytes was not observed (Tarlow et al.,
2014). To resolve this contradiction, we used a different BEC
fate-tracing model, Ck19-CreER;R26R-RFP mice (Figures 2A).
Direct RFP fluorescence combined with immunostaining for
Opn after four tamoxifen (TAM) injections showed an overall
BEC labeling efficiency of 10.5% ± 2.0%, with some bile ducts
Figure 2. Absence of BEC-Derived Hepato-
cytes
(A) The BEC fate-tracing model was generated by
injecting Ck19-CreER;R26R-RFP mice with 4 mg
TAM every other day for four injections total. Liver
injury was induced by CDE diet feeding 2 weeks
after the last TAM injection. Livers were analyzed
after 3 weeks of CDE diet feeding.
(B) Direct fluorescence of RFP combined with
immunostaining for Opn shows no RFP-positive,
Opn-negative cells; i.e., non-BECs/nonoval cells
derived from BECs.
(C) Direct fluorescence of RFP combined with
immunostaining for Mup shows no RFP-positive,
Mup-positive cells; i.e., hepatocytes derived from
BECs.
(D) The CDE-Stop model was generated as in (A)
with the difference that the mice were fed a normal
diet between CDE diet feeding and analysis.
(E) Direct fluorescence of RFP combined with im-
munostaining for Opn shows no RFP-positive,
Opn-negative cells; i.e., non-BECs/nonoval cells
derived from BECs.
(F) Direct fluorescence of RFP combined with im-
munostaining forMupshowsnoRFP-positive,Mup-
positive cells; i.e., hepatocytes derived from BECs.
Scale bars, 100 mm. At least three mice were
analyzed for each experiment. Representative
images are shown. See also Figure S2.showing >40% labeling; the frequency of labeled hepatocytes
was negligible (defined as <0.1% of the hepatocyte population)
(Figures S2A and S2B). Two weeks after the last TAM injection,
mice were fed the CDE diet for 3 weeks. Their injured livers
showed the expected fate-traced oval cells expressing RFP
and Opn, but fate-traced hepatocytes—identified by immuno-
staining for major urinary protein (Mup)—were present at a negli-
gible frequency (Figures 2Band2C). The frequency of fate-traced
hepatocytes remained negligible whenwe restricted our analysis
to portal regions with >40% labeling efficiency (53.5% ± 2.6%)
(Figure S2C), which suggested our results were not due to low la-
beling efficiency. Nevertheless, we reevaluated these results us-
ing a modified CDE diet model that was reported to yield higher
numbers of BEC-derived hepatocytes (2.45% versus 0.78%) by
allowing mice to recover from CDE-diet-induced chronic liver
injury for 2 weeks before analysis (Espan˜ol-Sun˜er et al., 2012)Cell Reports 8, 933–939(Figure 2D). Using this CDE-Stop model,
we still detected only a negligible number
of fate-traced hepatocytes in Ck19-
CreER;R26R-RFP mice (Figures 2E and
2F). These results argue against BECs,
or LSCs contained in biliary structures,
generating hepatocytes in mice with
CDE-diet-induced chronic liver injury.
Mesenchymal Cell Fate Tracing
in CDE-Diet-Induced Chronic
Liver Injury
Another potential alternative source of
hepatocytes are mesenchymal liver cells,among which stellate cells are intriguing candidates because
they undergo substantial changes in form and function when
they become activated in chronic liver injury, including after
CDE diet (Ueberham et al., 2010). Moreover, stellate cells are
considered to be the liver’s pericytes, a cell type that has been
implicated as a precursor of parenchymal cells in other tissues
(Dellavalle et al., 2007). Previous GFAP-based fate-tracing
studies reported that activated stellate cells—called myofibro-
blasts—contribute up to 24% of hepatocytes in mice with liver
injury (Michelotti et al., 2013; Swiderska-Syn et al., 2014; Yang
et al., 2008). However, these results were contradicted by a
recent fate-tracing study using lecithin-retinol acyltransferase
as amore specific stellate cell/myofibroblast marker (Mederacke
et al., 2013).
To independently assess the contribution of stellate cells/
myofibroblasts to hepatocyte regeneration, we performed fate, August 21, 2014 ª2014 The Authors 935
Figure 3. Absence of Mesenchymal Liver-
Cell-Derived Hepatocytes
(A) Pdgfrb-Cre;R26R-EYFP or Pdgfrb-Cre;R26R-
Confetti mice were used for fate tracing of stellate
cells/myofibroblasts. Livers were analyzed after
3 weeks of CDE diet feeding.
(B) Coimmunostaining for EYFP and desmin
shows no EYFP-positive, desmin-negative cells;
i.e., nonmesenchymal cells derived from stellate
cells/myofibroblasts.
(C) Coimmunostaining for EYFP and Mup shows
no EYFP-positive, Mup-positive cells; i.e., hepa-
tocytes derived from stellate cells/myofibroblasts.
(D) SM22-Cre;R26R-Confetti mice were used for
fate tracing of periportal mesenchymal cells.
Livers were analyzed after 4 weeks of CDE diet
feeding.
(E) Coimmunostaining for YFP/nGFP/mCFP (XFP)
and desmin shows that desmin-positive periportal
mesenchymal cells, but no cells with hepatocyte
morphology, are XFP positive.
(F) Coimmunostaining for YFP/nGFP/mCFP (XFP)
and Fah shows no XFP-positive, Fah-positive
cells; i.e., hepatocytes derived from periportal
mesenchymal cells.
Scale bars, 100 mm. At least three mice were
analyzed for each experiment. See also Figure S3.tracing based on platelet-derived growth factor receptor beta
(Pdgfrb) expression in mice fed CDE diet for 3 weeks (Figure 3A).
For this, we generated R26R-EYFP and R26R-Confetti mice car-
rying a Pdgfrb-Cre allele that was recently shown to be specif-
ically and efficiently expressed in stellate cells/myofibroblasts
(Henderson et al., 2013). Combining immunostaining for EYFP
or direct fluorescence of the Confetti markers (RFP, YFP,
mCFP, and nGFP; data not shown) with immunostaining for
themesenchymal cell markers desmin and alpha smoothmuscle
actin (aSma) or the hepatocyte markers Mup and Fah showed
fate tracing of stellate cells/myofibroblasts at >70% efficiency,
whereas the number of fate-traced hepatocytes was negligible
in both injured and noninjured livers (Figures 3B, 3C, and S3A–
S3C). This result suggests that stellate cells/myofibroblasts are
not a source of new hepatocytes in CDE-diet-induced chronic
liver injury.936 Cell Reports 8, 933–939, August 21, 2014 ª2014 The AuthorsA previous study aimed at identifying
LSCs based on label retention provided
evidence for candidate cells not only
residing in but also immediately adja-
cent to biliary structures (Kuwahara
et al., 2008). The identity of these cells
was not determined, but they appeared
to be located within the periportal mesen-
chyme. To investigate the possibility that
the periportal mesenchyme harbors cells
capable of hepatocyte differentiation, we
performed fate tracing using smooth
muscle protein 22 alpha (SM22)-Cre
mice, which were previously used for
specific gene knockout in the periportal
mesenchyme (Hofmann et al., 2010). Forthis, we generated SM22-Cre;R26R-Confetti mice and analyzed
their livers after 4 weeks of CDE diet feeding (Figure 3D). We
found >15% labeling efficiency of desmin-positive periportal
mesenchymal cells, whereas the number of labeled hepatocytes
was negligible in both injured and noninjured livers (Figures 3E,
3F, S3D, and S3E). Viewed together with our results obtained
by stellate cell/myofibroblast fate tracing, these results argue
against a contribution from mesenchymal liver cells to hepato-
cyte regeneration in chronic liver injury.
Refined Hepatocyte Fate Tracing in CDE-Diet-Induced
Chronic Liver Injury
Prompted by our inability to confirm previous reports of hepato-
cyte formation from BECs or mesenchymal liver cells—not even
at the low frequency observed in our hepatocyte fate-tracing
studies (Figure 1D)—we revisited this model. We hypothesized
Figure 4. Origin of New Hepatocytes from
Pre-Existing Hepatocytes
(A) A refined hepatocyte fate-tracing model was
generated by injecting AAV8-Ttr-Cre into R26R-
RFP mice and analyzing the liver of each mouse
before and after CDE diet feeding. For this,
mice were subjected to one-third PH 1 week after
AAV8-Ttr-Cre injection, followed by a 1.5-week-
long recovery phase. Final liver analysis was car-
ried out after 3 weeks of CDE diet feeding.
(B) Direct fluorescence of RFP combined with
immunostaining for Opn shows the characteristic
oval cell response after CDE diet feeding.
(C and D) Direct fluorescence of RFP combined
with immunostaining for Mup shows in livers of
mice after (C) and before (D) liver injury the pres-
enceofRFP-negative,Mup-positivecells; i.e., non-
fate-traced hepatocytes (arrowheads and insets).
(E) Quantification of non-fate-traced hepatocytes
in livers of mice before and after liver injury. Data
are shown as mean ± SEM; p > 0.1.
Scale bars, 100 mm. Representative images and
results from three mice are shown. See also Fig-
ure S4.that the small number of unlabeled hepatocytes observed in
our hepatocyte fate-tracing model was due to less than 100%
labeling efficiency of AAV8-Ttr-Cre, and not reflective of hepato-
cytes derived from nonhepatocytes. To address this possibility,
we repeated hepatocyte fate tracing with AAV8-Ttr-Cre using
different Cre reporter mice, R26R-RFP mice, which do not
require immunostaining as R26R-EYFP mice do but can be
analyzed by direct fluorescence (Figures 4A and S4A). In accord
with improved ability to detect labeled hepatocytes, we found a
slightly lower frequency of non-fate-traced hepatocytes of
0.40% ± 0.23% in R26R-RFP mice after 3 weeks of CDE diet
feeding (Figures 4B, 4C, and 4E). More importantly, sampling
of each mouse’s liver by one-third partial hepatectomy (PH)
before CDE diet feeding revealed the same frequency (0.39%
± 0.18%) of non-fate-traced hepatocytes as after CDE diet
feeding (Figures 4A, 4D, and 4E), confirming that the hepatocyte
labeling efficiency of AAV8-Ttr-Cre is not 100%. Furthermore,
the result indicates that non-fate-traced hepatocytes detected
after CDE diet feeding are not newly generated by a nonhepato-
cyte source but are pre-existing hepatocytes that were not
labeled by AAV8-Ttr-Cre. Thus, these results argue that newCell Reports 8, 933–939hepatocytes formed during CDE-diet-
induced chronic liver injury derive from
pre-existing hepatocytes and not other,
nonhepatocyte cell types such as LSCs.
DISCUSSION
Conflicting results have been reported
about the contribution of nonhepatocyte
cell types to liver regeneration. To
address the resulting uncertainty about
the significance, or even existence, of
LSCs, we used multiple fate-tracing stra-tegies in mice with CDE-diet-induced chronic liver injury, all of
which failed to provide convincing evidence for BECs or mesen-
chymal liver cells giving rise to new hepatocytes. Possibly, the
labeling efficiency in our Ck19-based or the recent Sox9-based
fate-tracing study by Tarlow et al. (2014) (10.5% ± 2.0% or7%,
respectively, versus 69.1% in the Opn or 28.7% in the Hnf1b
study) was not sufficient for capturing rare cells like LSCs. How-
ever, we also failed to find a significant number of fate-traced he-
patocytes when we restricted our analysis to periportal regions
with the highest labeling efficiency (53.5% ± 2.6%). Furthermore,
we confirmed our Ck19 and our Pdgfrb and SM22 expression-
based fate-tracing results by using our refined hepatocyte fate-
tracing approach, which was designed to detect even very rare
events by excluding intermouse variability.
The recent Sox9 study suggests unspecific fate tracing of
hepatocytes as an explanation for the discrepant results ob-
tained in previous BEC or stellate cell/myofibroblast fate-tracing
studies (Espan˜ol-Sun˜er et al., 2012; Furuyama et al., 2011; Mi-
chelotti et al., 2013; Rodrigo-Torres et al., 2014; Tarlow et al.,
2014). The authors show that TAM, which was needed to acti-
vate fate tracing in all of these studies, remains active in mouse, August 21, 2014 ª2014 The Authors 937
livers for a week and potentially longer. Initiating CDE diet
feeding or other injuries at this time—as done in the original
Sox9, Opn, Hnf1b and GFAP studies, but not in the recent
Sox9 study or our Ck19 study—may have resulted in marker
gene activation in injured hepatocytes that unspecifically ex-
pressed the genes whose promoters were used to drive Cre.
Our results also appear to be at odds with previous reports of
isolation of cells from adult mouse liver that express BEC
markers and can be expanded and differentiated into both hepa-
tocytes and BECs in vitro (Dorrell et al., 2011; Huch et al., 2013;
Shin et al., 2011). These differences suggest that removing liver
cells from their in vivo environment may confer properties of
plasticity not representative of in vivo biology. An alternative
explanation, at least in liver injury models, is that these cells
are hepatocytes that underwent biliary differentiation, but re-
tained the ability to convert back into hepatocytes (Michalopou-
los, 2014). Being derived from hepatocytes, such cells would not
have been identified as nonhepatocytes by our approach to he-
patocyte fate tracing.
An important implication of our inability to confirm previous
findings of nonhepatocytes giving rise to new hepatocytes is
that it calls into question whether adult mice have LSCs,
which—in the classical view—are defined as a hepatocyte-inde-
pendent backup system for liver regeneration. Despite many
published studies about LSCs, no direct in vivo evidence exists
supporting their existence, and conceivably the regenerative ca-
pabilities of hepatocytes—and their ability to undergo biliary dif-
ferentiation—have rendered LSCs expendable. Because our
approach to hepatocyte fate tracing allows investigation of the
hepatocyte population only as a whole, it remains to be deter-
mined whether LSC-like subsets of hepatocytes exist that are
more regenerative and/or plastic than others.
Another potential explanation for our findings is that current
mouse models of liver injury are insufficient for LSC activation.
Because LSCs are thought to serve as a backup system when
hepatocytes fail to proliferate, LSC activation may require a
true hepatocyte cell-cycle arrest. None of the currently available
mouse models of liver injury—including CDE diet feeding (Fig-
ures S4B and S4C)—block hepatocyte proliferation. Although
new mouse models could be developed, this question could
be addressed in rats where intoxication with 2-acetylaminofluor-
ene followed by two-thirds PH not only induces an oval cell
response, but also blocks hepatocyte proliferation (Trautwein
et al., 1999). Combining this protocol with tools for genetic fate
tracing in rats may reveal the existence of LSCs or BECs capable
of hepatocyte differentiation in vivo as recently reported for
zebrafish (Choi et al., 2014; He et al., 2014).
In conclusion, our findings provide no evidence for hepato-
cytes deriving from LSCs, or other nonhepatocyte cell types, in
mice with CDE-diet-induced chronic liver injury.EXPERIMENTAL PROCEDURES
Mice
R26R-EYFP (Srinivas et al., 2001), R26R-RFP (Luche et al., 2007), R26R-RFP
(Ai14) (Madisen et al., 2010), R26R-Confetti (Snippert et al., 2010), Ck19-
CreER (Means et al., 2008), Pdgfrb-Cre (Henderson et al., 2013), and SM22-
Cre (Hofmann et al., 2010) mice were used. All mice were kept under barrier938 Cell Reports 8, 933–939, August 21, 2014 ª2014 The Authorsconditions. All procedures were approved by the Institutional Animal Care
and Use Committee at UCSF.
Adenoassociated Virus
AAV8-Ttr-Cre was generated as previously described (Malato et al., 2011).
Purified virus was injected via the tail vein in <150 ml volume to avoid hydrody-
namic effects.
Choline-Deficient, Ethionine-Supplemented Diet
Mice 5.5–8.5 weeks of age and 20 g in body weight received choline-defi-
cient chow (MP Biomedicals) supplemented with 0.15% (w/v) ethionine
(E5139, Sigma-Aldrich) in drinking water.
Partial Hepatectomy
Removal of the left liver lobe (one-third of liver mass) was performed under
isoflurane anesthesia, buprenorphine analgesia, sterile conditions, and
homeothermia.
Tamoxifen
Tamoxifen (Sigma) was dissolved in sterile corn oil to a concentration of 40mg/
ml. Mice received a series of four intraperitoneal injections of 4 mg at 2 day
intervals.
Immunostaining
Tissue sampleswere fixed either by 4%PFA (Sigma) perfusion (R26R-RFP and
Confetti) or drop fixed overnight in 4% PFA (R26R-RFP), neutral-buffered
formalin containing zinc (Anatech), or 10% PBS-buffered formalin (R26R-
EYFP). Samples were embedded in OCT (Tissue-Tek) and cryosectioned
into 6-mm-thick sections or embedded in paraffin and cut into 5-mm-thick sec-
tions. Paraffin sections were treated with Antigen Retrieval Citra Solution (Bio-
Genex) before antibody staining. Sections were blocked in 10% serum for 1 hr
and incubated with primary antibodies at 4C overnight and secondary anti-
bodies at room temperature for 1 hr (Tables S1 and S2). DAPI (Millipore) was
used to stain nuclear DNA. Hnf4a immunostaining of paraffin-embedded sec-
tions was done using the M.O.M. kit (Vector Laboratories).
Cell Quantification
Periportal fields were randomly chosen from at least three lobes of each
mouse, with the exception of analysis of samples collected by one-third PH.
The overall number of hepatocytes per field was determined based on Mup
or Hnf4a andDAPI staining and the overall number of BECs per fieldwas deter-
mined based on Ck19 or Opn and DAPI staining. At least 10,000 hepatocytes
were counted for each experiment except for analyses of highly labeled portal
regions in Ck19-CreER;R26R-RFP mice and hepatocyte proliferation after
CDE diet, where 2,500 hepatocytes were counted.
Statistics
Data are shown as mean ± SEM. Statistical significance was determined using
the two-tailed Student’s t test.
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